Uveitis
📧 Sign up to get email alerts when something new happens for Uveitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study) [Phase 2]
A Phase 2 study evaluating adrenocorticotropic hormone (ACTH) using ACTHAR for uveitis has completed.
-
EMA approval · 2025-12-11EMA Authorised: Hyrimoz (adalimumab) — Sandoz GmbH
EMA authorised Hyrimoz (adalimumab) by Sandoz GmbH as a biosimilar to Humira for multiple inflammatory diseases, including rheumatoid arthri…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles [NA]
The University of Milan reports a clinical trial investigating immunosuppressive treatment for non-infectious uveitis guided by aqueous humo…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Metagenomics for Ocular Inflammation
A Moorfields Eye Hospital trial is recruiting to evaluate metagenomics for ocular inflammation, including uveitis and ocular infection. The …
-
EMA approval · 2025-10-24EMA Authorised: Ozurdex (dexamethasone) — AbbVie Deutschland GmbH & Co. KG
The European Medicines Agency authorised Ozurdex (dexamethasone intravitreal implant) for the treatment of macular edema and uveitis. The de…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-10-21EMA Authorised: Idacio (adalimumab) — Fresenius Kabi Deutschland GmbH
EMA authorised Idacio, a biosimilar of adalimumab, for multiple inflammatory diseases, produced by Fresenius Kabi Deutschland GmbH. The indi…
-
EMA approval · 2025-10-08EMA Authorised: Humira (adalimumab) — AbbVie Deutschland GmbH & Co. KG
The EMA authorised Humira (adalimumab) by AbbVie Deutschland GmbH & Co. KG for multiple indications including ankylosing spondylitis, juveni…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis [Phase 2]
This update reports the completion of a Phase 2 randomized trial comparing adalimumab, anakinra, and tocilizumab for non-infectious refracto…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore
This clinical trial update from the Singapore National Eye Centre reports demographics and clinical characteristics of ocular inflammatory d…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating adalimumab for uveitis in juvenile idiopathic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Evaluation of a Standardized Strategy for Uveitis Etiological Diagnosis [NA]
The trial evaluating a standardized strategy for etiologic diagnosis of uveitis has completed. The document does not report treatment result…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment [Phase 3]
Phase 3 trial update comparing two YUTIQ implants to sham for chronic non-infectious intraocular inflammation of the posterior segment; curr…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Characteristics of Ankylosing Spondylitis Associated Uveitis
A completed clinical trial update describing the characteristics of uveitis in patients with ankylosing spondylitis.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: AutoInflammatory Disease Alliance Registry (AIDA)
The AutoInflammatory Disease Alliance Registry (AIDA) is currently recruiting to collect data on hereditary autoinflammatory diseases. The c…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis [Phase 4]
Phase 4 clinical trial investigating therapeutic drug monitoring-guided de-escalation of adalimumab in non-infectious chronic uveitis.
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Adalimumab vs. Conventional Immunosuppression for Uveitis Trial [Phase 3]
Phase 3 trial comparing adalimumab to conventional immunosuppression for uveitis has completed. Results have been posted.
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study [Phase 1]
A Phase 1 clinical trial (LION Study) is evaluating the safety, tolerability, and distribution of Laquinimod Eye Drops for uveitis-related i…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Demographic Data and Clinical Presentation of Pediatric Uveitis
This clinical trial update summarizes demographic data and clinical presentation of pediatric patients with uveitis. The study is not yet re…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Adalimumab in JIA-associated Uveitis Stopping Trial [Phase 4]
Phase 4 trial of adalimumab for Juvenile Idiopathic Arthritis-associated uveitis has completed and posted results.
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Study of Risk Factors for Therapeutic Failure in Chronic Non-Infectious Uveitis After First-Line Immunosuppressive Therapy
An ongoing study sponsored by Centre Hospitalier Universitaire Amiens investigates risk factors for therapeutic failure in chronic non-infec…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Screening for Oculocerebral Lymphoma with the Phenotype of NK Cells in Patients with Uveitis [NA]
A clinical trial is currently recruiting to screen for oculocerebral lymphoma with the phenotype of natural killer (NK) cells in patients wi…
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis [Phase 2]
A Phase 2 clinical trial compares intravitreal versus subcutaneous adalimumab for non-infectious uveitis and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis [Phase 2]
ACELYRIN's Phase 2b pivotal study of Izokibep for non-infectious uveitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: The Effectivity of Anti Tuberculosis Therapy in Idiopathic Uveitis with Positive IGRA [Phase 2]
Phase 2 study assessing the effectiveness of anti-tuberculosis therapy in IGRA-positive uveitis, including tuberculous uveitis.
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV) [Phase 4]
Phase 4 trial evaluating safety and clinical efficacy of QLETLI in non-infectious uveitis is active but not currently recruiting.